tiprankstipranks
Gilead Sciences (DE:GIS)
XETRA:GIS
Holding DE:GIS?
Track your performance easily

Gilead Sciences (GIS) Income Statement

5 Followers

Gilead Sciences Income Statement

Last quarter (Q3 2024), Gilead Sciences's total revenue was $7.54B, an increase of 7.02% from the same quarter last year. In Q3, Gilead Sciences's net income was $1.25B. See Gilead Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 28.30B$ 27.12B$ 27.28B$ 27.30B$ 24.69B$ 22.45B
Cost of Revenue
$ 6.76B$ 6.50B$ 5.66B$ 6.60B$ 4.57B$ 4.67B
Gross Profit
$ 21.54B$ 20.62B$ 21.62B$ 20.70B$ 20.12B$ 17.77B
Operating Expense
$ 16.49B$ 12.96B$ 11.59B$ 10.79B$ 10.19B$ 8.44B
Operating Income
$ 822.00M$ 7.61B$ 7.33B$ 9.92B$ 9.93B$ 9.34B
Net Non Operating Interest Income Expense
$ -506.00M$ -944.00M$ -935.00M$ -1.00B$ -984.00M$ -995.00M
Other Income Expense
$ 4.03B$ -1.01B$ -4.22B$ 639.00M$ 7.27B$ 3.18B
Pretax Income
$ 176.00M$ 6.86B$ 5.81B$ 8.28B$ 1.67B$ 5.16B
Tax Provision
$ 62.00M$ 1.25B$ 1.25B$ 2.08B$ 1.58B$ -204.00M
Earnings From Equity Interest Net Of Tax
$ -3.88B$ -3.81B$ -3.73B$ -3.62B--
Net Income Common Stockholders
$ 127.00M$ 5.67B$ 4.59B$ 6.22B$ 123.00M$ 5.39B
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 23.25B$ 18.31B$ 16.31B$ 17.39B$ 14.76B$ 13.11B
Net Income From Continuing And Discontinued Operation
$ 127.00M$ 5.67B$ 4.59B$ 6.22B$ 123.00M$ 5.39B
Normalized Income
$ 4.49B---$ -4.54B$ -95.00M
Interest Expense
------
EBIT
$ 682.00M$ 7.80B$ 6.75B$ 9.28B$ 2.65B$ 6.16B
EBITDA
$ 3.44B$ 10.50B$ 8.85B$ 11.33B$ 4.13B$ 7.56B
Currency in USD

Gilead Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis